Characterization of human platelet binding of recombinant T cell receptor ligand

BACKGROUND: Recombinant T cell receptor ligands (RTLs) are bio-engineered molecules that may serve as novel therapeutic agents for the treatment of neuroinflammatory conditions such as multiple sclerosis (MS). RTLs contain membrane distal α1 plus β1 domains of class II major histocompatibility compl...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Itakura, Asako, Aslan, Joseph E, Sinha, Sushmita, White-Adams, Tara C, Patel, Ishan A, Meza-Romero, Roberto, Vandenbark, Arthur A, Burrows, Gregory G, Offner, Halina, McCarty, Owen JT
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2010
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2992052/
https://ncbi.nlm.nih.gov/pubmed/21059245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-7-75
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires